{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:25:37Z","timestamp":1785601537905,"version":"3.56.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["emed.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Emergency Medicine Clinics of North America"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.emc.2015.04.008","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T05:05:02Z","timestamp":1434085502000},"page":"597-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Atrial Fibrillation"],"prefix":"10.1016","volume":"33","author":[{"given":"Eric","family":"Goralnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Bontempo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.emc.2015.04.008_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.annemergmed.2007.03.007","article-title":"Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004","volume":"51","author":"McDonald","year":"2008","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.emc.2015.04.008_bib2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.emc.2015.04.008_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.emc.2015.04.008_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.emc.2015.04.008_bib5","first-page":"e91","article-title":"Heart disease and stroke statistics\u20142010 Update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.emc.2015.04.008_bib6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.emc.2015.04.008_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A\u00a0population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study","volume":"113","author":"Stewart","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.emc.2015.04.008_bib8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.emc.2015.04.008_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1524-4733.2006.00124.x","article-title":"Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States","volume":"9","author":"Coyne","year":"2006","journal-title":"Value Health"},{"key":"10.1016\/j.emc.2015.04.008_bib10","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1161\/CIR.0b013e318214876d","volume":"123","author":"Fuster","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.emc.2015.04.008_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annemergmed.2010.07.005","article-title":"Variation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departments","volume":"57","author":"Stiell","year":"2011","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.emc.2015.04.008_bib12","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMcp041956","article-title":"Clinical practice. Newly diagnosed atrial fibrillation","volume":"351","author":"Page","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.emc.2015.04.008_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ahj.2004.09.038","article-title":"Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"149","author":"Curtis","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.emc.2015.04.008_bib14","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A\u00a0comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.emc.2015.04.008_bib15","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A\u00a0comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.emc.2015.04.008_bib16","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/CIRCULATIONAHA.106.177292","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.emc.2015.04.008_bib17","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jacc.2010.09.013","volume":"57","author":"Fuster","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.emc.2015.04.008_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIR.0b013e31820f14c0","article-title":"2011 ACCF\/AHA\/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"123","author":"Wann","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.emc.2015.04.008_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.hfc.2013.07.004","article-title":"Ventricular rate control of atrial fibrillation in heart failure","volume":"9","author":"Rienstra","year":"2013","journal-title":"Heart Fail Clin"},{"issue":"1","key":"10.1016\/j.emc.2015.04.008_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.hrthm.2010.11.047","article-title":"2011 ACCF\/AHA\/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"8","author":"Wann","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.emc.2015.04.008_bib22","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/j.1875-9114.1997.tb03087.x","article-title":"Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter","volume":"17","author":"Phillips","year":"1997","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.emc.2015.04.008_bib23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ajem.2010.03.021","article-title":"Low-dose diltiazem in atrial fibrillation with rapid ventricular response","volume":"29","author":"Lee","year":"2011","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.emc.2015.04.008_bib24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0735-1097(98)00561-0","article-title":"Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens","volume":"33","author":"Farshi","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0733-8651(03)00111-5","article-title":"Pharmacological rate control of atrial fibrillation","volume":"22","author":"Tamariz","year":"2004","journal-title":"Cardiol Clin"},{"issue":"5","key":"10.1016\/j.emc.2015.04.008_bib26","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1016\/j.ijcard.2013.10.040","article-title":"Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function","volume":"169","author":"Patel","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib27","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/01.CIR.101.11.1282","article-title":"Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks","volume":"101","author":"Mittal","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.emc.2015.04.008_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pcad.2005.06.006","article-title":"Cardioversion of atrial fibrillation","volume":"48","author":"Gowda","year":"2005","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.emc.2015.04.008_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0002-9149(91)90707-R","article-title":"Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter","volume":"68","author":"Van Gelder","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eupc.2003.09.010","article-title":"Incidence and management of early recurrent atrial fibrillation (ERAF) after transthoracic electrical cardioversion","volume":"6","author":"Siaplaouras","year":"2004","journal-title":"Europace"},{"key":"10.1016\/j.emc.2015.04.008_bib31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2459\/01.JCM.0000203851.75020.bd","article-title":"Is pretreatment with ibutilide useful for atrial fibrillation cardioversion when combined with biphasic shock?","volume":"7","author":"Mazzocca","year":"2006","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.emc.2015.04.008_bib32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0002-9149(99)80655-9","article-title":"Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation","volume":"75","author":"Donovan","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib33","doi-asserted-by":"crossref","first-page":"50A","DOI":"10.1016\/0002-9149(92)91078-I","article-title":"Efficacy of flecainide for the reversion of acute onset atrial fibrillation","volume":"70","author":"Donovan","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib34","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0002-9149(00)01128-0","article-title":"Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm","volume":"86","author":"Martinez-Marcos","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9149(92)91392-H","article-title":"Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension","volume":"70","author":"Capucci","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-5273(02)00467-9","article-title":"Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation","volume":"87","author":"Khan","year":"2003","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib37","series-title":"Atrial fibrillation. National clinical guideline for management in primary and secondary care","author":"National Collaborating Centre for Chronic Conditions (UK)","year":"2006"},{"key":"10.1016\/j.emc.2015.04.008_bib38","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/hc4101.097538","article-title":"Electrophysiological effects of ibutilide in patients with accessory pathways","volume":"104","author":"Glatter","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.emc.2015.04.008_bib39","first-page":"37","article-title":"Ibutilide for cardioversion of atrial flutter: efficacy of a single dose in recent-onset arrhythmias","volume":"52","author":"Ando","year":"2004","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.emc.2015.04.008_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2003.04.055","article-title":"Torsade de pointes: the clinical considerations","volume":"96","author":"Gowda","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijcard.2008.12.012","article-title":"Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter","volume":"141","author":"Steinwender","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0167-5273(02)00477-1","article-title":"Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation","volume":"89","author":"Khan","year":"2003","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib43","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","article-title":"Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study","volume":"102","author":"Singh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.emc.2015.04.008_bib44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0735-1097(96)00506-2","article-title":"Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators","volume":"29","author":"Falk","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib45","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0002-8703(99)70363-7","article-title":"Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group","volume":"137","author":"Norgaard","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.emc.2015.04.008_bib46","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.emc.2015.04.008_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S1481803500012227","article-title":"Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter","volume":"12","author":"Stiell","year":"2010","journal-title":"CJEM"},{"key":"10.1016\/j.emc.2015.04.008_bib48","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","article-title":"Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study","volume":"36","author":"Marini","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.emc.2015.04.008_bib49","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.emc.2015.04.008_bib50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.emc.2015.04.008_bib51","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation\u2013developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.emc.2015.04.008_bib52","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation Cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.emc.2015.04.008_bib53","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/STROKEAHA.110.609297","article-title":"Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores inpatients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring","volume":"42","author":"Boriani","year":"2011","journal-title":"Stroke"},{"issue":"19","key":"10.1016\/j.emc.2015.04.008_bib54","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"European Heart Rhythm Association","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.emc.2015.04.008_bib55","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.emc.2005.07.013","article-title":"Management of atrial fibrillation in the emergency department","volume":"23","author":"Raghavan","year":"2005","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.emc.2015.04.008_bib56","doi-asserted-by":"crossref","first-page":"615","DOI":"10.7326\/0003-4819-126-8-199704150-00005","article-title":"Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours","volume":"126","author":"Weigner","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.emc.2015.04.008_bib57","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0735-1097(00)01178-5","article-title":"Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation","volume":"37","author":"Klein","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.emc.2015.04.008_bib58","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.emc.2015.04.008_bib59","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.emc.2015.04.008_bib60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0002-9343(02)01131-2","article-title":"Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial","volume":"113","author":"Matchar","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.emc.2015.04.008_bib61","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(10)61194-4","article-title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial","volume":"376","author":"Wallentin","year":"2010","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.emc.2015.04.008_bib62","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.emc.2015.04.008_bib63","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus Warfarin in Patients with Atrial Fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.emc.2015.04.008_bib64","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.emc.2015.04.008_bib65","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1553-2712.2007.tb02337.x","article-title":"Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter","volume":"14","author":"Stiell","year":"2007","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.emc.2015.04.008_bib66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0300-9572(00)00180-5","article-title":"Termination of recent-onset atrial fibrillation\/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion","volume":"45","author":"Domanovits","year":"2000","journal-title":"Resuscitation"},{"key":"10.1016\/j.emc.2015.04.008_bib67","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.annemergmed.2010.09.027","article-title":"Emergency department management and 1-year outcomes of patients with atrial flutter","volume":"57","author":"Scheuermeyer","year":"2011","journal-title":"Ann Emerg Med"}],"container-title":["Emergency Medicine Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862715000322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862715000322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T13:26:53Z","timestamp":1717939613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733862715000322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0733862715000322"],"URL":"https:\/\/doi.org\/10.1016\/j.emc.2015.04.008","relation":{},"ISSN":["0733-8627"],"issn-type":[{"value":"0733-8627","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Emergency Medicine Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.emc.2015.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}